Cargando…
Original insights on thrombospondin-1-related antireceptor strategies in cancer
Thrombospondin-1 (TSP-1) is a large matricellular glycoprotein known to be overexpressed within tumor stroma in several cancer types. While mainly considered as an endogenous angiogenesis inhibitor, TSP-1 exhibits multifaceted functionalities in a tumor context depending both on TSP-1 concentration...
Autores principales: | Jeanne, Albin, Schneider, Christophe, Martiny, Laurent, Dedieu, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625054/ https://www.ncbi.nlm.nih.gov/pubmed/26578962 http://dx.doi.org/10.3389/fphar.2015.00252 |
Ejemplares similares
-
Editorial: Matricellular Receptors As Potential Targets in Anti-Cancer Therapeutic Strategies
por: Emonard, Hervé, et al.
Publicado: (2016) -
Deciphering the complex role of thrombospondin-1 in glioblastoma development
por: Daubon, Thomas, et al.
Publicado: (2019) -
Identification of TAX2 peptide as a new unpredicted anti-cancer agent
por: Jeanne, Albin, et al.
Publicado: (2015) -
LRP-1 Promotes Cancer Cell Invasion by Supporting ERK and Inhibiting JNK Signaling Pathways
por: Langlois, Benoit, et al.
Publicado: (2010) -
Low-Density Lipoprotein Receptor-Related Protein-1 Mediates Endocytic Clearance of Tissue Inhibitor of Metalloproteinases-1 and Promotes Its Cytokine-Like Activities
por: Thevenard, Jessica, et al.
Publicado: (2014)